News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Injection to aid treatment of mental illness

7 September 2005

Injection to aid treatment of mental illness

Patients living with psychoses will have a new funded treatment option from 1 October 2005, with PHARMAC’s decision to list the injectable form of the antipsychotic medicine risperidone.

Risperdal Consta will be targeted to those patients whose symptoms are not controlled on currently funded treatments. The injection is longer-lasting than tablets and its use can help control the symptoms of patients who can’t take other forms of antipsychotic medicines.

PHARMAC Acting Medical Director Dr Dilky Rasiah says the decision to list Risperdal Consta is in response to evidence and comments PHARMAC has received from clinicians treating patients with psychoses.

“Doctors have told us that they consider this an important treatment option to have funded, so it is pleasing to reach an agreement to enable it to be funded,” says Dr Rasiah.

“Having an injected form of risperidone available can help patients better control their symptoms and can avoid the need for them to be managed in a hospital setting. This can help them return to life in the community earlier which has a significant positive effect on these patients and their families.”

In addition to funding Risperdal Consta, the agreement with pharmaceutical company Janssen Cilag will also see risperidone orally-disintegrating tablets (Risperdal Quicklets) funded.

The agreement is the latest step PHARMAC has taken to enhance the range of treatments available for people with mental illness. Last year PHARMAC widened access to the atypical antipsychotic olanzapine and listed dissolvable olanzapine wafers (Zyprexa Zydis).

Antipsychotic medicines have been the single largest area of growth in the pharmaceutical budget, climbing from $4.9 million in 1998 to $47.4 million last year, a near 10-fold increase.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION